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Abstract: Histone post-translational modifications (PTMs) positively and negatively regulate gene expression, and are 
consequently a vital influence on the genomic profile of all eukaryotic species. The study of histone PTMs using classical 
methods in molecular biology, such as immunofluorescence and Western blotting, is challenging given the technical is-
sues of the approaches, and chemical diversity and combinatorial patterns of the modifications. In light of these many 
technical limitations, mass spectrometry (MS) is emerging as the most unbiased and rigorous experimental platform to 
identify and quantify histone PTMs in a high-throughput manner. This review covers the latest developments in mass 
spectrometry for the analysis of histone PTMs, with the hope of inspiring the continued integration of proteomic, genomic 
and epigenetic research. 
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THE EMERGING RELEVANCE OF EPIGENETICS 
FOR GENOMICS 
  A major goal in genomics is the holistic understanding of 
a specific cellular process gained through the study of an 
organism’s genome. An important yet commonly unexplored 
complement to this analysis is a consideration of the epige-
netic influences that impinge on eukaryotic gene expression 
[1]. The first of these pathways is DNA methylation on cyto-
sine nucleotides, which is generally associated with the si-
lencing of imprinted genes. Levels of DNA methylation are 
maintained by DNA methyltransferases against dilution re-
sulting from DNA replication. Various enzymatic families 
such as the AlkB family of demethylases, the DME/ROS1 
family of glycosylases, and the AID family of cytidine 
deaminases are also known to remove DNA methylation [2]. 
In the specific context of imprinting, several DEMETER-like 
demethylases localize to the 5’ and 3’ ends of genes and are 
believed to protect endogenous genes from excessive DNA 
methylation occurring on nearby transposable elements in A. 
thaliana [3]. Another epigenetic pathway involves both 
small and long non-coding RNAs, where small non-coding 
interference RNA mediated heterochromatin formation at the 
centromeres has been documented in S. pombe and D. mela-
nogaster [4] and that long non-coding RNAs has recently 
been shown to activate gene expression [5]. 
  Finally, epigenetic regulation can proceed via the chro-
matin associated proteins called histones (the core histone 
subtypes H2A, H2B, H3, and H4, and the linker histone H1). 
Although histones were once regarded to be general tran-
scriptional repressors due to their coiling of promoter DNA 
into the nucleosome, these proteins are currently regarded to 
have both activation and silencing regulatory influences on 
gene expression [6, 7]. Most histone subtypes exist as multi-
ple sequence variants [8, 9]. The selective deposition of   
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histone variants may lead to different transcriptional outputs. 
For instance, while the H3 variant H3.3 is generally linked to 
gene activation, the H3 variant H3.2 is linked to gene silenc-
ing [10]. In addition to occurring as sequence variants, his-
tones can be extensively post-translationally modified with 
acetylation (ac), methylation (me), phosphorylation (ph), 
ubiquitination (ub), and other moieties on a residue-specific 
basis [11]. Given the broad chemical diversity of modifica-
tion moieties found on histones, it is perhaps not surprising 
that a similarly broad diversity of enzymes are responsible 
for the formation and removal of the modifications. In the 
case of histone demethylation for instance, at least two dis-
tinct enzymatic families exist, namely the flavin- and iron-
dependent classes of demethylases [12]. How these post-
translational modifications (PTMs) are linked to epigenetic 
regulation is not fully understood. Current models propose 
that these PTMs act as binding sites for other regulatory pro-
teins that themselves effect transcriptional regulation [13].  
  Genomics research has uncovered several striking corre-
lations between specific histone PTMs and specific gene 
regions, mostly using ChIP-Seq. Notable among these corre-
lations is the enrichment of trimethylation of lysine 4 on his-
tone H3 (H3K4me3) over the promoters of active genes and 
the enrichment of H3K36me3 over the structural coding re-
gion of those genes in murine embryonic stem cells [14]. A 
recent study applied this correlation and mapped H3K4me3 
to the rhesus macaque genome with the aim of identifying 
novel transcription start sites [15]. A similar approach to 
identifying novel transcription factor binding sites in murine 
macrophages has been performed by mapping genomic re-
gions enriched with histone acetylation [16]. Equally inter-
esting discoveries concern the interplay between DNA 
methylation and histone modifications. For instance, the 
methylation-specific transcriptional repressor MeCP2 was 
shown to co-immunoprecipitate with the Sin3 histone deace-
tylase in X. laevis oocytes. The activity was MeCP2 was 
further demonstrated to negatively correlate with the overall 
histone acetylation state [17]. Perhaps the strongest lines of 
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were the isolation of mutations in dim-5 and KYP in screens 
for DNA methylation defective lines in N. crassa [18] and 
for suppressors of aberrant DNA methylation in A. thaliana 
respectively [19]. Subsequent biochemical assays demon-
strated that both gene products were in fact histone methyl-
transferases.  
  With increasing discoveries of and growing interest to-
wards the functions histone modifications perform for epige-
netic regulation, the question arises of how one first discov-
ers and quantifies histone PTMs. Histone modifications were 
first explored with radiolabeling, as was the case with the 
biochemical characterizations of the first histone acetyltrans-
ferase [20] and methyltransferase [21]. Since radiolabeling 
lacks sufficient specificity for studying PTMs on a residue 
specific basis, researchers began to rely on the antigenicity 
of particular PTMs. For instance, indirect immunofluo-
resence studies determined that K12 acetylation on histone 
H4 (H4K12ac) is not enriched on any chromosome in D. 
melanogaster, while H4K16ac is enriched on the male X 
chromosome over autosomes and the female X chromo-
somes [22].  
  Another common antibody-based approach is Western 
Blotting [23]. Western blots helped determine that H2b 
monoubiquitination is enriched in the more transcriptionally 
active macronucleus of T. thermophila, while H2A monou-
biquitination shows a less dramatic enrichment in the macro-
nucleus over the micronucleus [24]. However, with anti-
body-based approaches such as immunofluoresence, Western 
Blots, and even ChIP-seq, issues with epitope occlusion and 
cross-reactivity arise and are difficult to control properly. A 
specific case of epitope occlusion is the difference in anti-
body recognition of H3S10 phosphorylation depending on 
whether the nearby residues H3K9 and H3K14 are unmodi-
fied or acetylated [25]. In fact, such an influence on PTM 
binding from the combinatorial influence of nearby residues 
is predicted to have epigenetic consequences in the form of 
binary switches. The binding of one protein such as hetero-
chromatin protein 1 (HP1) to methylated H3K9, which can 
initiate and maintain heterochromatin, may be impeded by 
phosphorylated H3S10 [26]. A potential case of cross reac-
tivity could be the assignment of biotinylation on histones as 
novel PTMs [27]. Much of the antibody-based supporting 
evidence for histone biotinylation has been questioned fol-
lowing a study that determined that streptavidin reactivity 
could be a possible source of non-specific interaction [28].  
  In light of the various shortcomings with radiolabeling 
and antibody-based approaches, mass spectrometry (MS) is 
emerging as an experimental platform for identifying and 
quantifying histone PTMs. Unlike radiolabeling, MS analy-
sis allows for site-specific localization of specific histone 
PTMs, and unlike antibody-based methods, MS analysis 
allows for unbiased quantification of histone PTMs. Fur-
thermore, the recent advancements in mass spectrometric 
analysis are possible to a great extent through parallel ad-
vancements in other fields. Thus, this review will not only 
discuss the latest techniques of mass spectrometry, but also 
in chromatography, ionization techniques, and in computa-
tional software, that have enabled the high-throughput analy-
sis of histone PTMs. 
FUNDAMENTALS OF MASS SPECTROMETRY 
  Before discussing particular MS applications for histone 
PTM analysis, it is informative to first review the principles 
of MS analysis. In general, the mass spectrometer measures 
the behavior of freely moving gas-phase ions in electric 
and/or magnetic fields. The property measured, such as the 
time required for an ion to reach the detector, or the fre-
quency of the image current transient induced by an oscillat-
ing ion, depends on the mass/charge ratio (m/z) of the ion.  
  In a mass spectrum, the m/z value of peptide ions are 
displayed. Given sufficient mass accuracy, from this value 
alone, one can deduce the composition but not the amino 
acid sequence of the peptides. For instance, both the se-
quences PEPTIDE and EDITPEP share the same m/z value 
(800.368 m/z for the [M+H] singly charged ion). Addition-
ally, peptides with the same sequence containing different 
sites of modification such as the 9-17 peptide on histone H3 
monomethylated (me1) either on K9 or K14 and unmodified 
(un) on the other lysine residue (H3K9me1K14un or 
H3K9unK14me1 respectively) share the same m/z value 
(542.312  m/z for the [M+2H] doubly charged ion). Even 
different modifications such as trimethylation and acetyla-
tion give the same nominal mass shift of 42 Da and thus ap-
pear identical in a relatively low mass accuracy instrument 
such as a linear ion trap. The two modifications actually dif-
fer by 0.036 m/z, and this seemingly minute difference can 
be distinguished with a higher accuracy instrument such as a 
Fourier transform ion cyclotron resonance mass spectrometer 
or an Orbitrap mass spectrometer [29].  
  To determine unambiguously the peptide sequence, one 
needs to isolate the desired peptide ion and fragment the ion 
into its smaller, typically N- or C-terminus containing frag-
ments. The fragments are subsequently revealed in the 
MS/MS spectrum (Fig. 2). The efficiency of fragmentation, 
signal-to-noise ratio, and other features subsequently influ-
ence the confidence of assigning a particular peptide se-
quence and modification state to a particular MS/MS and to 
the respective precursor ion in the MS. Such caution is espe-
cially warranted given several documented cases of induced 
migration or scrambling of the methyl group from one his-
tone residue to another during CID fragmentation and lead-
ing to PTM misidentification [30, 31].  
BOTTOM UP MASS SPECTROMETRY FOR HIS-
TONE ANALYSIS 
  There are various different MS experimental designs that 
can be performed for histone PTM quantification, each re-
quiring different sample preparation steps, chromatography, 
and MS/MS fragmentation mode (Fig. 1). Perhaps the most 
straight-forward approach is bottom up MS analysis. In gen-
eral, bottom up MS refers to the sequencing and quantifica-
tion of proteolytic, often tryptic, peptides [32, 33]. Trypsin is 
widely considered to be the ideal protease for most bottom 
up applications, including histone analysis, due to its cata-
lytic robustness, relative affordability, and high specificity 
for lysines and arginines [34]. However, the lysine- and ar-
ginine-rich histones would be digested by trypsin into very 
small peptides with poor chromatographic retention. Addi-
tionally, the frequent adjacency of lysines and arginines, for 
example R8 and K9 on histone H3 and K16 and R17 on his-
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on the respective proteins. Thus quantification of these his-
tone PTMs would rely on missed-cleavage events that are 
prone to poor reproducibility. Furthermore, the PTMs them-
selves often block trypsin digestion, causing missed cleav-
ages for some modified peptides where unmodified or less 
modified versions of the same peptide digest into normal 
tryptic peptides. For example, a histone H3 protein unmodi-
fied on K9 would produce a different tryptic peptide than 
another H3 protein trimethylated on K9. While a difference 
in modification state, such as unmodified and trimethylation, 
may lead to differences in the ionization efficiencies of both 
peptides, a difference in the peptide sequence has a greater 
likelihood to affect the ionization efficiencies even more. 
This subsequently makes the relative quantification of both 
modified sites with respect to each other more challenging.  
  To resolve these histone-specific incompatibilities with 
trypsin digestion, one must first derivatize the histones. One 
of the earliest methods was deuteroacetylation, where deu-
terated acetyl groups are added to all unmodified lysines, and 
hyperacetylated histone peptides are formed [35]. ‘Hyperace-
tylated’ peptides denote peptides where every lysine is acety-
lated. Under reversed phase chromatography, all hyperacety-
lated peptides of the same primary sequence co-elute at ef-
fectively the same retention time. While this derivatization 
 
 
 
 
 
 
 
 
 
Fig. (1). Typical experimental design for bottom up, middle down, and top down MS analysis of histone PTMs. Abbreviations: RP-LC = 
reversed phase-liquid chromatography; WCX-HILIC = weak cation exchange-hydrophilic interaction liquid chromatography; CID = colli-
sional induced dissociation; ETD = electron transfer dissociation. 
Fig. (2). Example of MS/MS for the H3 9-17 peptide trimethylated on K9 acquired from a bottom up MS experiment. All other residues on 
this peptide are unmodified. Relative intensity of 1.0 denotes the intensity of the most abundant CID fragment ion in the spectrum, namely 
the b7 ion. Arrows indicate the b and y fragment ion peaks of a given charge state and m/z value that were positively annotated. Hatched 
marks above and below the peptide sequence also correspond to the b and y fragment ions respectively found in the MS/MS. Abbreviation: 
pr = propionyl group.  
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seemingly erases the original modification patterns on the 
histones, in fact the difference in mass between the original 
and deuterated acetyl groups (m = 3.018 Da) allows one to 
determine the original number of acetyl groups. Deuteroace-
tylation continues to be an effective approach and was re-
cently used to determine the changes in histone PTM levels 
resulting from incubating 293T cells with derivatives of 
pyridine-2,4-dicarboxylic acid, which inhibit the JMJD2 
methyltransferase [36].  
  Another method of derivatization relies on propionic an-
hydride to derivatize histones [37]. In contrast to deuteroace-
tylation, propionylation occurs on both unmodified and 
monomethylated lysines as well as the N-terminal amine. 
The addition of a propionyl moiety ( = 56.026 Da) not only 
prevents trypsin digestion at lysines, but also imparts addi-
tional hydrophobicity to the histone peptide. The increase in 
hydrophobicity enhances the chromatographic resolution 
between different histone peptides, as well as different modi-
fied forms of the same peptide. A second derivatization after 
trypsin digestion adds another propionyl group to the newly 
created N-terminus.  
  A useful variation of this technique is to use deuterated 
d10-propionic anhydride where the hydrogens on the reagent 
are replaced with deuteriums, similar to the deuterated d3-
acetic anhydride described previously [38]. Here, one can 
use d10-propionic anhydride after trypsin digestion to label 
the N-terminus of all the histone peptides and results in an 
additional mass shift of 5.031 Da, beyond the mass of regu-
lar propionic anhydride derivatization. One can then mix two 
different histone samples, where one is treated with d0-
propionic anhydride and the other with d10-propionic anhy-
dride, to quantify the relative difference in histone levels in a 
single MS experiment by using the ratio between the isotopic 
pairs. Recently, this differential labeling was used to deter-
mine changes in histone methylation and acetylation on mul-
tiple residues on H3 and H4 resulting from knock-down of 
the methyltransferase G9a/GLP1, which previously was 
known only to methylate H3K9 [39].  
IMPORTANCE OF CHROMATOGRAPHY IN BOT-
TOM UP AND MIDDLE DOWN HISTONE MS 
EXPERIMENTS  
  No discussion on proteomics would be complete without 
describing the importance of chromatographic separations. 
The opposite of chromatographic separation is direct infu-
sion of the sample into the mass spectrometer, where the 
entire sample is introduced into the mass spectrometer at 
once. Although technically simpler to set up, there are a va-
riety of features that make direct infusion particularly ill-
suited for bottom up histone analysis. First, the simultaneous 
presence of all the various modified histone forms results in 
ionization suppression of relatively low abundant histone 
peptides by more abundant histone peptides. Second, the 
lack of chromatographic resolution means that isobaric his-
tone peptides, such as the unmodified 9-17 H3 peptide 
(H3K9un, 535.304 m/z) and the monomethylated and 
monoacetylated 9-17 H3 peptide (H3K9me1K14ac1, 
535.304 m/z) to directly overlap with each other. Quantifica-
tion of these two peptides would rely on deconvolution of 
the fragment ions in the MS/MS for the 535.304 m/z ion, and 
is generally a complicated computational problem. Despite 
these shortcomings, direct infusion has traditionally been 
extensively used for top down histone protein analysis, for 
reasons as described later. For bottom up and middle down 
mass spectrometry, though, the use of reversed-phase and 
hydrophilic-interaction liquid chromatography respectively 
are essential in the resolution and quantification of highly 
modified histone peptides (Fig. 3).  
MULTIPLEXING IN BOTTOM UP MS FOR COM-
PARATIVE HISTONE ANALYSIS 
  To increase the throughput of histone modification analy-
sis, one can use more intricate isotopic labeling schemes for 
the histone peptides. As already described, d10-propionic 
anhydride can be used for comparative analysis on different 
histone samples. Another method for histone labeling is iso-
baric tag for relative and absolute quantification or iTRAQ. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). Reversed phase liquid chromatography resolves the various modified forms of the 9-17 H3 peptide resulting from propionic anhy-
dride derivatization and trypsin digestion. Each line represents an extracted ion chromatogram for peptide ions of a particular m/z value, 
namely at 535.304, 542.312, 521.307, and 528.315 m/z. The relative elution order for the unmodified and modified forms of the 9-17 peptide 
can be predicted on the basis on the number of propionyl, methyl, and acetyl groups.  110    Current Chemical Genomics, 2011, Volume 5  Zee et al. 
For each sample, a unique isobaric tag is added to all pri-
mary amines of the peptide after trypsin digestion, and all 
the samples are mixed together in equal proportions before 
mass spectrometry analysis. Each tag is comprised of a re-
porter and balancer component, and while the net mass of 
the tag (i.e. reporter1 + balancer1 = reporter2 + balancer2) is 
constant and equal between differentially tagged samples, 
the masses of the internal components vary. In the unfrag-
mented full mass spectra, the same histone peptide from the 
various samples will exactly overlap with each other. The 
differentiation of the peptides from each sample is deter-
mined from the MS/MS spectra, where upon CID fragmenta-
tion, the reporter tag is released. It is the relative abundances 
of the unique reporter tags in a given MS/MS that informs 
the relative abundances of the histone peptide from each 
sample.  
  iTRAQ has so far been used to quantify differences in 
histone variant protein levels between samples, such as be-
tween protein fractions unbound and bound to barrier-to-
autointegration factor [40] and between highly tumorigenic 
cancer lines and their relatively less tumorigenic parental 
line [41]. Despite the promise iTRAQ has for differential 
PTM analysis, one notable disadvantage of iTRAQ is the 
reliance of quantification from the MS/MS spectrum. De-
pending on the efficiency of the precursor ion selection and 
fragmentation, quantification from the MS/MS spectrum 
may be more susceptible to noise than quantification from 
the MS spectrum. 
  Derivatization with either d10-propionic anhydride or 
iTRAQ reagents allows for high-throughput histone analysis, 
and occurs post-sample collection. An alternative mode of 
histone labeling that occurs pre-sample collection is termed 
“stable isotope labeling by amino acids in cell culture” or 
SILAC, which was originally developed for the analysis of 
the whole proteome rather than only the histones [42]. For 
SILAC, the cells from which histones will be harvested are 
grown in tissue culture media containing isotopically heavier 
amino acids such as 
13C6
15N2-lysine, as opposed to the far 
more abundantly occurring 
12C6
14N2-lysine isotope in nature. 
If histones are to be harvested from tissue, the organism is 
fed with a diet where the appropriate amino acid is substi-
tuted. By replacing any of the essential amino acids with the 
heavier isotope and allowing the cells enough time to me-
tabolize the isotope, the histones should fully incorporate the 
label. Thus, one can mix samples from heavy isotope treated 
and regular cells together and perform the standard workflow 
for MS analysis without any further specialized reagents. 
SILAC has recently been used to understand the PTM pro-
files on histones H3 and H4 from four human breast cancer 
lines and a wild type line [43].  
  There are several key limitations to SILAC. For instance, 
SILAC cannot be performed for human clinical samples for 
ethical and practical considerations, although as discussed 
below, newer applications have partly circumvented this 
dilemma. Both iTRAQ and d10-propionic anhydride can, in 
principle, be applied to any histone sample regardless of 
their origin. In addition, the duration of SILAC labeling must 
be sufficient for near total labeling of the histones. Gener-
ally, the slowest turnover for intracellular proteins at steady 
state is equal to the duration of a single cell cycle, where half 
of the histone proteins are newly synthesized. Thus, the frac-
tion of remaining metabolically unlabeled histones can be 
approximated to be (1/2)^n, where n is the number of cell 
cycles carried out in the experiment. Thus, one must wait 
until the histones become sufficiently fully labeled before 
performing any experiments and MS analysis. Additionally, 
the cost of supplementing isotopically labeled amino acids 
into tissue culture media may prove more expensive than 
derivatization approaches. 
  Despite the shortcomings, one advantage of SILAC for 
histone analysis is the potentially greater mass shift offered 
than d10-propionic anhydride, reducing the risk of histone 
peptide isotope distributions to overlap with each other. 
13C6
15N2-lysine has a mass shift of 8.014 Da, and 
13C6
15N4-
arginine has a mass shift of 10.008 Da, and since most bot-
tom up histone peptides contain one lysine and one arginine, 
one can usually observe a mass shift of over 18 Da. Further-
more, despite the problem with residual unlabeled proteins 
due to cell turnover, the efficiency of metabolic labeling is 
generally higher and more easily reproducible than the effi-
ciency of acetic or propionic anhydride derivatization and 
thus allows the analysis of lower quantity samples [42]. Fi-
nally, with regard to the incompatibility between SILAC and 
clinical samples, super-SILAC has been developed as a rela-
tively cost-effective method to circumvent this limitation 
[44]. A complex proteomic mixture derived from multiple 
cell lines cultured in heavy-isotope media is used as a type of 
standard that can be subsequently spiked into clinical sam-
ples [45]. The use of multiple lines instead of one increases 
the likelihood for full coverage of the potentially complex 
sample proteome, allowing for direct SILAC comparison. In 
this respect, super-SILAC can be regarded as a proteomic 
analogue of universal reference RNA commonly used for 
microarray analysis [46].  
MS APPROACHES TO ANALYZING HISTONE 
PHOSPHORYLATION AND OTHER PTMs 
  One of the features that complicate histone PTM analysis 
is the sheer diversity of modifications found on histones. 
Traditionally, the diversity of histone PTMs that could be 
analyzed was limited to the diversity of primary antibodies 
available. Apart from this technical shortcoming, a larger 
and more fundamental problem with Western Blots and im-
munofluorescence is that such antibody-based approaches 
require a priori knowledge of what modifications to look for. 
Truly discovery-based screens for novel histone modifica-
tions or modification patterns simply could not be per-
formed. Mass spectrometry currently holds the most promise 
for such endeavors.  
  Bottom up MS analysis of histone acetylation and methy-
lation is relatively a straight-forward technical problem, with 
acetylated and methylated peptides usually amenable to 
standard CID fragmentation. Histone phosphorylation poses 
a unique challenge for MS analysis, due partly to the general 
need for enrichment using some variation of metal affinity 
resin but mostly due to the relatively labile nature of the 
phosphate bond relative to the methyl or acetyl bond during 
CID fragmentation. The increased likelihood for loss of the 
phosphate group from the peptide, and thus the inability to 
localize the phosphate to a specific residue in the MS/MS, 
means a different mode of fragmentation is required, namely 
electron transfer dissociation (ETD). Relative to CID, ETD Quantitative Proteomic Approaches to Studying Histone Modifications  Current Chemical Genomics, 2011, Volume 5    111 
fragmentation is less biased towards the nature of the amino 
acid side chains, and by extension the post-translational 
modification attached to the side chain, and provides a more 
evenly distributed fragmentation pattern along the peptide 
backbone [47]. Thermodynamically labile modifications 
generally remain intact with strong preference for cleavage 
along the peptide backbone. ETD has proven quite success-
ful in studying histone phosphorylation, with various novel 
sites identified in H1 variants from asynchronous HeLa cells 
[48] and from mouse and rat testes [49]. Given the utility of 
ETD sequencing of phosphorylated peptides, one may won-
der why not all MS experiments operate in ETD mode. 
Aside from limited availability of ETD in select mass spec-
trometers, the more crucial limitation is the requirement for 
higher peptide charge states for effective ETD fragmenta-
tion. The combination of chemical derivatization and trypsin 
digestion usually results in +2 charged histone peptides, 
which is ideal for CID fragmentation but barely amenable to 
ETD fragmentation. 
  In addition to studying histone phosphorylation, mass 
spectrometry can also be used to study more unique PTMs. 
The modification of serine and threonine histone residues by 
-N-acetylglucosamine was verified using a clever series of 
chemical derivatization steps to produce a peptide amenable 
for CID sequencing [50]. A recent survey of protein ubiquit-
ination in a transgenic Arabidopsis line expressing His-
tagged ubiquitin monomers also used CID sequencing to 
identify several novel sites on histone H1.2 [51]. Collec-
tively, these examples illustrate the versatility of mass spec-
trometry to identify a broad range of histone PTMs.  
MIDDLE DOWN MASS SPECTROMETRY FOR 
COMBINATORIAL PTM ANALYSIS 
  Thus far, MS analysis on histone PTMs may appear to be 
restricted to relatively small tryptic peptides that contain 1-4 
potential sites of modification. Yet histones are notable for 
being highly modified proteins that may potentially contain 7 
or more modified sites. To understand the connectivity be-
tween modifications on different histone residues, one must 
analyze larger peptides that encompass more modified sites. 
Bottom up analysis is unable to link, for instance, H3K9me3 
to H3K27me3 because both sites occur on separate tryptic 
peptides. To isolate these larger peptides, alternative prote-
ases to trypsin must be used. GluC or V8 protease digest 
histone H3 into the 1-50 peptide and encompasses most of 
the known modified residues on the H3 N-terminal tail ex-
cept K56 and K79, which have been documented to be acety-
lated [52] and methylated [53] respectively. Middle down 
MS analysis of the 1-50 peptide can thus link H3K9me3 with 
H3K27me3, which could not otherwise be accomplished 
with bottom up analysis (Fig. 4). AspN digests histone H4 
into the 1-24 peptide, and encompasses all the known modi-
fied residues on the H4 tail.  
  The longer histone peptides, with more lysines and argin-
ines, logically possess higher charge states and are thus more 
amenable to ETD sequencing than CID sequencing. More 
crucially though, is that the longer histone peptides require a 
different mode of chromatography for sufficient resolution 
of the modified forms. For much the same reasons that 
propionylated tryptic histone peptides are conducive to re-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (4). Example of MS/MS for the H3 1-50 peptide trimethylated on K9 and K27 (H3K9me3K27me3) acquired from a middle down MS 
experiment. All other residues on this particular H3 peptide are unmodified. Relative intensity of 1.0 denotes the intensity of the most abun-
dant ETD fragment ion in the spectrum, namely the c4 ion. Arrows indicate the c and z fragment ion peaks of a given charge state that were 
positively annotated. Hatched marks above and below the peptide sequence also correspond to the c and z fragment ions respectively found 
in the MS/MS.  112    Current Chemical Genomics, 2011, Volume 5  Zee et al. 
versed phase separation, GluC- or AspN-digested histone 
peptides are not conducive for reversed phase. In particular, 
the 1-50 H3 peptide produced from GluC digestion and 1-24 
H4 peptide produced from AspN digestion are both highly 
charged and hydrophilic peptides that would likely elute in 
the void volume of a reversed phase gradient, as peptides 
bind and elute based on hydrophobocity. Hydrophilic inter-
action liquid chromatography (HILIC), essentially the oppo-
site of reversed phase chromatography, is ideal for dealing 
with these larger and more hydrophilic histone peptides and 
was initially applied for middle down histone analysis as an 
offline prefractionation means to resolve different modified 
forms [54]. A newer variation of HILIC supplements resolu-
tion by hydrophilicity with resolution by charge using cation 
exchange chromatography and allows for direct interfacing 
with the mass spectrometer [55].  
  This gain of information on the connectivity between 
different modified residues on the same protein in middle 
down mass spectrometry comes at the cost of reduced sensi-
tivity compared to bottom up mass spectrometry. There are 
at least two reasons for the reduced sensitivity, and both 
concern an effective dilution of signal. First, a longer histone 
peptide can exist in a more disperse range of charge states. 
Bottom up histone peptides mostly exist in charge states of 
z=1-3 and usually just one or at most two of those is domi-
nant. For larger, more highly charged peptides, such as the 1-
50 peptide on histone H3, an broad envelope of charge states 
is generally observed and four to six charge states can be 
major contributors to signal [55]. Consequently, the overall 
peptide signal is distributed over more charge states. Second, 
any gain of information about how PTMs exist in combina-
tion comes at the cost of diluting the signal for any one inde-
pendently considered site. The number of modified versions 
of a peptide increases as the number of variable sites of 
modification are considered in combination. For example, 
there are more than ten of thousand combinations of modifi-
cations possible on the intact 1-50 peptide of histone H3. 
The bottom up mass spectrometry approach collapses these 
down to tens of modified peptides (including both different 
sequences and modification states), thus concentrating signal 
in fewer analytes, but sacrificing molecular connectivity of 
the PTMs. Just considering the K4 monomethyl species there 
are over a thousand middle down peptides all of which con-
tain H3 monomethylated at K4 (e.g. H3K4me1K36me1, 
H3K4me1K9me2K27me2, etc.) but there is only one in the 
bottom up analysis: H3K4me1. This amount of this one pep-
tide present is equal to the sum of the thousand or more mid-
dle down peptides. In reality this effect is much lower than 
theoretically expected due to high biological specificity of 
how PTMs exist in combination. 
TOP DOWN MASS SPECTROMETRY FOR FULL 
COMBINATORIAL PTM ANALYSIS  
  As mentioned, middle down MS analysis achieves nearly 
full combinatorial analysis on histone H3. One would imag-
ine that the simplest solution to analyze all the modified sites 
on histone H3 would be to sequence the intact non-digested 
protein, and indeed, such an approach has already been per-
formed and is termed top down MS analysis. Although not 
as widely implemented as bottom up or middle down mass 
spectrometry, top down mass spectrometry has successfully 
been used recently to discover H2BK37me2 as a novel 
modified residue in S. cerevisiae and various phosphoryla-
tion sites on histone H1 variants, such as H1.4S187ph, en-
riched on promoters for rDNA and glucocorticoid response 
elements in HeLa cells [56, 57]. However, the same reasons 
why middle down MS analysis are less sensitive compared 
to bottom up analysis are exacerbated for top down analysis, 
where charge state and combinatorial PTM-dilution effects 
are compounded when considering the full length protein. In 
addition, the chromatographic behavior of full-length histone 
proteins is more difficult to predict than smaller peptides and 
for this reason direct infusion has typically been used for top 
down analysis [58]. This approach inherently yields poor 
resolution of modified forms. This means that the promise of 
true site specificity and molecular connectivity is often lost 
when multiple forms that share characteristic ions are present 
as such mixed spectra usually can not be deconvolved. 
  Much recent progress in chromatography has been 
achieved to implement this important step for top down MS 
analysis. Reversed phase chromatography using ultra-high 
pressure liquid chromatography has identified very abundant 
acetylated and methylated forms for all 4 core histone sub-
types extracted from immortalized human embryonic fibro-
blasts, yet lacked sufficient resolution to study modifications 
on a site-specific basis [59]. A more extensive survey of in-
tact histone modified forms from human fibroblasts was 
achieved by resolving proteins first with weak cation ex-
change-HILIC and second with reversed phase chromatogra-
phy for two-dimensional HPLC separation [60]. Despite 
these improvements, more progress in top down histone 
chromatography is needed for top down histone PTM analy-
sis to accurately and fully characterize the multitude of 
modified forms that might be observed with sensitivities 
approaching bottom up or middle down histone studies. Yet, 
such approaches are appealing as such data would ultimately 
reflect the complete, fully characterized true identity of the 
histone proteins, as they exist in nature. 
CONCLUSION 
  Despite important technical limitations particularly with 
chromatography that remain for MS analysis, mass spec-
trometry is emerging as a vibrant and versatile experimental 
platform that can perform comparative PTM analysis be-
tween multiple histone samples and even analyze combinato-
rial PTM patterns. The quantitative rigor and high-
throughput characterization of modifications enabled by MS 
should serve as a valuable complement for genomic studies 
into the epigenetic role chromatin plays in gene expression.  
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